Frequent Guidewire passage into the Pancreatic duct is an independent risk factor for Post-endoscopic Retrograde Cholangiopancreatography (ERCP) pancreatitis (PEP) among high risk individuals: A post-hoc analysis of a randomized controlled trial data.
Mahesh K GoenkaVenkata S AkshintalaAyesha KamalVenkata S AkshintalaNikhil BushVijay KumarMadhurima ChakrabortyMerve GurakarSundeep LakhtakiaRupjyoti TalukdarGuru TrikudanathanMouen A KhashabAnthony N KallooD Nageshwar ReddySaroj K SinhaVikesh K SinghRakesh KochharPublished in: Journal of digestive diseases (2023)
More than two guidewire passes into the PD, pancreatic brush cytology increased while the use of LR decreased the risk of PEP, respectively, among high-risk patients receiving rectal indomethacin. Pancreatic stent placement and/or LR should be considered in those patients in whom there are more than 2 passes of the guidewire into the PD. https://clinicaltrials.gov/ct2/show/NCT02116309. This article is protected by copyright. All rights reserved.